Can Steroids Make You Tired? How Cortisol Disrupts Sleep and Recovery

Yes, steroids can make you tired, and corticosteroids are the most common culprits. Roughly 14 to 20 percent of long-term users report fatigue in pooled safety data, per the 2012 Fardet meta-analysis. Corticosteroids raise glucose, break down muscle protein, and blunt the overnight cortisol drop that should precede sleep. Anabolic steroids cause fatigue more indirectly, mainly by degrading sleep quality and mood rather than by direct sedation. The tiredness is usually a dose-dependent drug effect, not a sign of weakness, and it reverses after tapering in most people.

The fatigue mechanism: how steroids drain energy

Cortisol is not a sedative. It is a glucocorticoid that mobilizes fuel, and at pharmacological doses it presses the body's emergency energy buttons continuously. That constant mobilization has a cost, which is where fatigue begins.

The first layer is the HPA axis. Endogenous cortisol peaks roughly 30 to 45 minutes after waking and falls to its lowest point around midnight. Oral prednisone at 10 mg or more floods receptors around the clock, so the hypothalamus and pituitary stop issuing their own signal. The adrenal glands then quiet down. When the drug level dips, the body runs on a flattened cortisol curve, and morning energy collapses first. In plain terms: the drug replaces the body's alarm clock, then leaves it unset.

The second layer is fuel handling. Glucocorticoids drive hepatic gluconeogenesis, which pulls amino acids from muscle. They also suppress protein synthesis in skeletal muscle by roughly 15 to 30 percent within the first week of high-dose therapy. Over 8 to 12 weeks of continuous treatment, patients can lose 2 to 5 percent of lean mass. Less muscle means more effort for every movement, and the mismatch between available energy and demand reads as fatigue.

The third layer is sleep architecture. A single evening dose of prednisone can delay sleep onset by 30 to 60 minutes and suppress REM sleep. Nighttime cortisol also suppresses melatonin secretion, the hormone that normally rises after dark. The result is a night of shallow, fragmented sleep followed by a cortisol surge at 4 a.m. that wakes the person early. Poor sleep and daytime exhaustion reinforce each other across weeks.

The fourth layer is downstream chemistry. High glucocorticoid exposure lowers testosterone and disrupts thyroid hormone conversion. Both changes reduce energy, motivation, and recovery capacity. Affective symptoms complete the picture: high doses trigger hypomania in roughly 3 to 6 percent of users in the first weeks, followed by a mood crash that feels identical to fatigue.

How often steroids cause fatigue: prevalence and dose thresholds

Fatigue is a predictable side effect, not a rare one, and its frequency scales with dose, duration, and the condition being treated. The pooled estimate of 14 to 20 percent comes from trials in which patients took corticosteroids for inflammatory disease, so individual risk varies widely.

For context, chronic fatigue affects roughly 5 to 10 percent of the general adult population and 20 to 30 percent of people with chronic inflammatory disease such as rheumatoid arthritis or lupus. Steroid users sit above the general-population baseline but below the disease-matched comparison, which suggests the drug adds a measurable but moderate increment. Patients with adrenal insufficiency, who lack cortisol entirely, report fatigue at rates approaching 80 percent, and Cushing's syndrome patients report it in roughly 70 percent. Steroid-induced fatigue sits at the milder end of that spectrum.

The dose relationship is the most useful number for prediction. Prednisone at 7.5 mg daily or less carries little fatigue risk. Doses from 7.5 to 30 mg daily produce moderate risk, and doses above 30 mg daily for more than three weeks substantially raise the odds of sleep disruption, mood change, and next-day exhaustion. Dexamethasone equivalence differs; 0.75 mg of dexamethasone matches about 5 mg of prednisone, so the milligram number on the bottle is not comparable across drugs.

The timeline: how steroid fatigue unfolds over time

The time course matters because early steroid fatigue looks nothing like late steroid fatigue. The table below follows the typical pattern across both major drug classes.

The timeline runs differently for anabolic steroids, which drive fatigue through sleep, mood, and muscle rather than glucose. Users typically report fatigue appearing between weeks 4 and 8 of a cycle, coinciding with mood instability, sleep apnea worsening, and the cumulative strain of elevated blood pressure. A long ester such as testosterone enanthate releases over 2 to 4 weeks, so the drug's decline after a cycle can bring a crash of low energy as endogenous testosterone remains suppressed.

Variations: corticosteroids, anabolic steroids, and who is most susceptible

Not every steroid produces the same fatigue profile. Inhaled and topical corticosteroids carry minimal systemic absorption, and fatigue is rare at standard doses. Low-dose oral prednisone under 7.5 mg daily is well tolerated by most people, though sleep timing still matters. High-dose pulse therapy, such as 1,000 mg of intravenous methylprednisolone daily for three to five days, causes acute sleep disruption in roughly half of patients, with a distinct fatigue wave in the following week.

Anabolic-androgenic steroids behave differently. Testosterone at replacement doses of roughly 50 to 100 mg per week improves fatigue in hypogonadal men. Supraphysiological doses of 500 to 1,000 mg per week, typical of bodybuilding use, are associated with worsened sleep apnea, mood swings, and elevated blood pressure, all of which drain energy. Oral anabolic agents such as oxandrolone at 20 to 80 mg daily are less directly sedating but add liver enzyme elevation and a muscle-versus-fuel imbalance during training.

Individual susceptibility matters as much as the drug. Being over age 60, being female, carrying a depression or anxiety diagnosis, having a BMI above 30, or already suffering from a sleep disorder multiplies the fatigue risk. Patients taking steroids for inflammatory disease also carry the fatigue of the underlying illness, which makes attributing symptoms to the drug harder.

The myth that steroids give you energy

The popular belief that steroids are energy drugs comes from two real phenomena that are routinely misread. The first is the brief euphoria some patients feel in the first one to two weeks of corticosteroid therapy, which feels like energy but is really a drug-induced mood lift accompanied by poor sleep. That lift is a known side effect, not a benefit. The second is the gym narrative that anabolic steroids are pure performance fuel, which ignores that sleep quality, blood pressure, and mood often get worse before training results improve.

A second misconception is that steroid fatigue equals weakness. Fatigue is a subjective exhaustion at rest, while weakness is a measurable loss of muscle power. Steroid myopathy, a real condition in high-dose users, produces weakness that is worst in the hips and shoulders and makes stair climbing difficult. If your legs simply feel heavy walking across a room, that is a different problem that needs medical evaluation.

A third misconception is that stopping the drug fixes everything immediately. The HPA axis can take 3 to 12 months to recover after prolonged suppression, and some users experience withdrawal fatigue, muscle aches, and low mood for weeks after their last dose. Tapering under medical supervision shortens and softens that dip.

The fourth misconception is that fatigue proves the steroid is the only problem. Fatigue has many causes, including anemia, thyroid disease, depression, sleep apnea, and the inflammatory condition the steroid is treating. Blaming the drug without checking those causes can delay treatment of something reversible.

Red flags: when fatigue is not just the steroid

Some fatigue patterns point to a complication rather than an expected side effect. The list below covers the situations that warrant prompt medical attention, because each reflects a treatable or dangerous process that gets worse if ignored.

• Weakness that steadily worsens over weeks, especially in the hips and shoulders, with difficulty standing from a chair or climbing stairs. This suggests steroid myopathy rather than ordinary fatigue.
• Sudden shortness of breath or chest pain within hours or days of an injection or high dose. Corticosteroid pulses and anabolic steroids both raise clot and cardiovascular risk.
• Abdominal pain, vomiting, and profound weakness after stopping steroids abruptly. These are possible signs of adrenal crisis, a medical emergency.
• New hip or knee pain that develops months into therapy. Avascular necrosis of the femoral head is an uncommon but well-documented corticosteroid complication.
• Yellowing of the eyes or skin, dark urine, or severe upper-right abdominal pain in anabolic steroid users. These signal liver injury.
• Deepening depression, suicidal thoughts, or a manic episode. Steroid-induced mood syndromes need urgent clinical review.

What to actually do about steroid-related fatigue

The most effective fix is manipulating timing before changing dose. Taking oral corticosteroids in the morning, ideally between 6 and 8 a.m., aligns the drug peak with the body's own cortisol rhythm and limits sleep disruption. If a twice-daily schedule is prescribed, asking the prescriber whether daytime doses can be moved earlier is a reasonable conversation. Evening dosing should be avoided whenever clinically possible.

Tapering is the second lever. Doses above 30 mg daily for more than three weeks should be reduced gradually under medical supervision rather than stopped abruptly. The exact schedule is clinical, but the principle is universal: slower tapers produce less withdrawal fatigue.

Tracking is the third lever. A simple daily diary of sleep hours, fatigue score, and dose timing reveals whether symptoms follow the drug or something else. It also gives the prescriber objective data for adjusting therapy instead of guessing.

Screening is the fourth lever. A blood panel should check thyroid function, ferritin, vitamin B12, vitamin D, and testosterone for men. Anyone with loud snoring, morning headaches, or daytime sleepiness should be screened for obstructive sleep apnea, particularly anabolic steroid users with new snoring.

Supportive steps help in the meantime. Keep sleep and wake times consistent, protect 7 to 9 hours in bed, and avoid late caffeine. Gentle walking or resistance bands maintain muscle without overreaching. If mood symptoms emerge, treat them as a medical issue rather than a character flaw.

What the evidence cannot yet tell us

The prevalence figures come from pooled meta-analyses, which combine patients with different diseases and doses, so they cannot predict any single person's risk. Most anabolic steroid fatigue data come from self-reported surveys with reporting and recall bias. No study has measured fatigue with a single standardized instrument across both drug classes, so the 14 to 20 percent and 20 to 40 percent estimates are not directly comparable. The mechanistic link between steroid-induced sleep apnea and daytime fatigue is plausible and supported by observational data, but causal trials do not exist and probably never will. Fatigue from steroids is real, common, and dose-dependent, but the strength of evidence differs between corticosteroids, where it is well documented, and anabolic steroids, where it remains partly inferential.